These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1069 related items for PubMed ID: 23394782

  • 21. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y, Kim TH, Park JK, Eum JH, Lee HJ, Kim J, Lyu SW, Kim YS, Lee WS, Yoon TK.
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [Abstract] [Full Text] [Related]

  • 22. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW, Chai J, Li RH, Lee VC, Ho PC, Ng EH.
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [Abstract] [Full Text] [Related]

  • 23. Antimüllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng/mL versus 1-4 ng/mL.
    Kavoussi SK, Odenwald KC, Boehnlein LM, Summers-Colquitt RB, Pool TB, Swain JE, Jones JM, Lindstrom MJ, Lebovic DI.
    Fertil Steril; 2015 Sep; 104(3):633-6. PubMed ID: 26144573
    [Abstract] [Full Text] [Related]

  • 24. Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.
    Baker VL, Gracia C, Glassner MJ, Schnell VL, Doody K, Coddington CC, Shin SS, Marshall LA, Alper MM, Morales AJ, Pavone ME, Behera MA, Zbella EA, Shapiro BS, Straseski JA, Broyles DL.
    Fertil Steril; 2018 Aug; 110(3):506-513.e3. PubMed ID: 29960708
    [Abstract] [Full Text] [Related]

  • 25. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K.
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM, Guibourdenche J, Birkhäuser MH, Bersinger NA.
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome.
    Reichman DE, Goldschlag D, Rosenwaks Z.
    Fertil Steril; 2014 Apr; 101(4):1012-8.e1. PubMed ID: 24491452
    [Abstract] [Full Text] [Related]

  • 35. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction.
    Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J.
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1107-14. PubMed ID: 23408576
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C.
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [Abstract] [Full Text] [Related]

  • 38. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.
    D'Amato G, Caroppo E, Pasquadibisceglie A, Carone D, Vitti A, Vizziello GM.
    Fertil Steril; 2004 Jun; 81(6):1572-7. PubMed ID: 15193479
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.